UK markets closed

Corline Biomedical AB (CLBIO.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
10.30+0.10 (+0.98%)
At close: 04:17PM CEST
Currency in SEK

Valuation measures4

Market cap (intra-day) 219.21M
Enterprise value 202.21M
Trailing P/E 302.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.11
Price/book (mrq)2.33
Enterprise value/revenue 7.48
Enterprise value/EBITDA -267.47

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-2.86%
S&P500 52-week change 321.08%
52-week high 319.85
52-week low 310.00
50-day moving average 312.40
200-day moving average 314.21

Share statistics

Avg vol (3-month) 310.29k
Avg vol (10-day) 37.16k
Shares outstanding 521.49M
Implied shares outstanding 621.49M
Float 819.37M
% held by insiders 154.83%
% held by institutions 114.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -5.09%
Operating margin (ttm)-6.91%

Management effectiveness

Return on assets (ttm)-1.11%
Return on equity (ttm)-1.92%

Income statement

Revenue (ttm)35.52M
Revenue per share (ttm)1.65
Quarterly revenue growth (yoy)-13.00%
Gross profit (ttm)N/A
EBITDA -1.69M
Net income avi to common (ttm)-1.81M
Diluted EPS (ttm)-0.04
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)17.01M
Total cash per share (mrq)0.79
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.51
Book value per share (mrq)4.34

Cash flow statement

Operating cash flow (ttm)886k
Levered free cash flow (ttm)-9.06M